Clinical Trial Update: Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study update evaluating LME636 for acute anterior uveitis; the trial was completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis

Drugs mentioned

• LME636

Snippet

Sponsor: Alcon Research | Conditions: Acute Anterior Uveitis | Phase 2 | Status: COMPLETED | Results posted: 2017-08-28